Safety & Recalls

Latest News

Brexpiprazole Approved as First Drug for Agitation Related to Dementia in Adults with Alzheimer’s Disease
Brexpiprazole Approved as First Drug for Agitation Related to Dementia in Adults with Alzheimer’s Disease

May 12th 2023

The FDA approved Rexulti (brexpiprazole) for Alzheimer’s-related agitation based on the findings of two clinical trials.

FDA Requires New Warnings For Prescription Opioids in Another Step to Prevent Overdoses
FDA Requires New Warnings For Prescription Opioids in Another Step to Prevent Overdoses

April 21st 2023

AbbVie Withdraws Two Blood Cancer Indications From Imbruvica
AbbVie Withdraws Two Blood Cancer Indications From Imbruvica

April 11th 2023

FDA Officially Withdraws Makena, the Only Preterm Birth Med
FDA Officially Withdraws Makena, the Only Preterm Birth Med

April 7th 2023

Impurities Lead to Recall of 10 Lots of Dabigatran
Impurities Lead to Recall of 10 Lots of Dabigatran

March 23rd 2023

More News

© 2023 MJH Life Sciences

All rights reserved.